tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Moleculin Biotech announces results from Phase 1 trial of WP1066
PremiumThe FlyMoleculin Biotech announces results from Phase 1 trial of WP1066
24d ago
Moleculin Biotech Regains Nasdaq Compliance
Premium
Company Announcements
Moleculin Biotech Regains Nasdaq Compliance
25d ago
Moleculin Biotech target adjusted to $31 from $300 at Roth Capital
Premium
The Fly
Moleculin Biotech target adjusted to $31 from $300 at Roth Capital
26d ago
Moleculin Biotech provides update on enrollment for MIRACLE study
PremiumThe FlyMoleculin Biotech provides update on enrollment for MIRACLE study
1M ago
Moleculin Biotech Partners with CIC biomaGUNE for Research
Premium
Company Announcements
Moleculin Biotech Partners with CIC biomaGUNE for Research
1M ago
Moleculin Biotech announces new Annamycin collaboration in brain tumors
Premium
The Fly
Moleculin Biotech announces new Annamycin collaboration in brain tumors
1M ago
Moleculin Biotech Releases Corporate Presentation Update
PremiumCompany AnnouncementsMoleculin Biotech Releases Corporate Presentation Update
2M ago
Moleculin Biotech Appeals Nasdaq Delisting Decision
Premium
Company Announcements
Moleculin Biotech Appeals Nasdaq Delisting Decision
2M ago
MBRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MBRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100